Atlas Trials

Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay

Clinical trial NCT03558165 · COMPLETED

Trial details

NCT number
NCT03558165
Sponsor
University Health Network, Toronto
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Cancer Stage IV
Start date
2018-03-01
Primary completion
2020-08-20
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.